TY  - JOUR

T1  - Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

JO  - The Lancet Infectious Diseases

PY  - 2022/11/19

AU  - Khoo SH

AU  - FitzGerald R

AU  - Saunders G

AU  - Middleton C

AU  - Ahmad S

AU  - Edwards CJ

AU  - Hadjiyiannakis D

AU  - Walker L

AU  - Lyon R

AU  - Shaw V

AU  - Mozgunov P et al

ED  - 

DO  - DOI: 10.1016/s1473-3099(22)00644-2

PB  - Elsevier BV

Y2  - 2024/12/26

ER  -